NETRIS Pharma Alternatives & Competitors
12 companies similar to NETRIS Pharma
Companies similar to NETRIS Pharma
XenTech
Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 y...
Semafore Pharmaceuticals
Pioneering the future of cancer treatment with innovative PI3K inhibitors.
Nilogen Oncosystems
We analyze cancer drug responses using fresh patient tumor tissue with intact tumor microe...
Nanoligent
Our mision is to improve the life of patients by designing new drugs that selectively targ...
Rival Readout
Competing with NETRIS Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Nirogy Therapeutics
Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing...
Genus Oncology LLC
Discovering New Frontiers in Anti-Cancer Therapeutics: Targeting MUC1 for a Healthier Tomo...
Peptomyc
Developing Peptides to treat Cancer
Sumitomo Pharma Oncology
is part of Sumitomo Pharma America as of July 2023
BiPar Sciences
Innovative therapies harnessing the power of PARP inhibitors to combat advanced cancers
Incyclix Bio
Regaining Cell Cycle Control
SwaLife Biotech
SwaLife Biotech finds plant molecules for cosmetics and creates anticancer alkaloids targe...
About NETRIS Pharma
NETRIS Pharma is a biotechnology company based in France, focusing on the development of innovative cancer-fighting therapies. Established in 2008, the company has garnered attention due to its unique integration within the renowned Léon Bérard Cancer Center in Lyon, France. Their research is driven by a distinguished...
Development of first-in-class therapeutics targeting Netrin-1 to overcome resistance in oncology
Patients with cancer, medical professionals, research institutions
Cancer Research, Pharmaceutical Industry, Therapeutic Molecules, Drug Development, Cellular Mechanisms, Léon Bérard Cancer Center, Dependence Receptors, Tumor Development, In Vitro Research, In Vivo Research, Preclinical Practices, Breast Cancer Treatment, Lung Cancer Treatment, Glioblastoma Treatment
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around NETRIS Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at NETRIS Pharma on 11 Jun 2025. The 12 companies listed here were last checked between 26 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.